Immunotherapies for advanced hepatocellular carcinoma.

Sun, Li-Yang; Zhang, Kang-Jun; Xie, Ya-Ming; Liu, Jun-Wei; Xiao, Zun-Qiang

Sun, Li-Yang; Zhang, Kang-Jun; Xie, Ya-Ming; Liu, Jun-Wei; Xiao, Zun-Qiang.

Afiliação

Sun LY; The Second School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China.
Zhang KJ; Cancer Center, General Surgery, Department of Hepatobiliary and Pancreatic Surgery and Minimally Invasive Surgery, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China.
Xie YM; The Second School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China.
Liu JW; Cancer Center, General Surgery, Department of Hepatobiliary and Pancreatic Surgery and Minimally Invasive Surgery, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China.
Xiao ZQ; Cancer Center, General Surgery, Department of Hepatobiliary and Pancreatic Surgery and Minimally Invasive Surgery, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China.

Front Pharmacol ; 14: 1138493, 2023.

Article em En | MEDLINE | ID: mdl-37025485

Palavras-chave

CTLA-4; PD-1; PD-L1; hepatocellular carcinoma; immunotherapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: Front Pharmacol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google